Real-Life Effectiveness of MP-AzeFlu (Dymista(®)) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale

BACKGROUND: Many allergic rhinitis (AR) patients have moderate/severe persistent disease. MP-AzeFlu (Dymista(®)) comprises intranasal azelastine hydrochloride and fluticasone propionate in a novel formulation delivered in a single device. OBJECTIVE: This prospective, noninterventional study assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Stjärne, Pär, Nguyen, Duc Tung, Kuhl, Hans Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826638/
https://www.ncbi.nlm.nih.gov/pubmed/36628265
http://dx.doi.org/10.2147/POR.S375403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826638/
https://www.ncbi.nlm.nih.gov/pubmed/36628265
http://dx.doi.org/10.2147/POR.S375403

Ejemplares similares